Table 3.
Hazard ratios for cause-specific mortality per SD of FFA in Cardiovascular Health Study
| Number of vents | HR | Model 1 95% CI | p-value | HR | Model 2 95% CI | p-value | |
|---|---|---|---|---|---|---|---|
| Cardiovascular | 1,155 | 1.08 | (1.01, 1.14) | 0.02 | 1.08 | (1.01, 1.15) | 0.02 |
| Cancer | 729 | 1.02 | (0.95, 1.11) | 0.55 | 1.05 | (0.96, 1.14) | 0.29 |
| Dementia | 502 | 1.27 | (1.16, 1.39) | <0.001 | 1.32 | (1.20, 1.44) | <0.001 |
| Infection | 288 | 1.23 | (1.09, 1.38) | 0.001 | 1.25 | (1.10, 1.41) | 0.001 |
| Respiratory | 199 | 1.26 | (1.10, 1.45) | 0.001 | 1.23 | (1.06, 1.43) | 0.007 |
| Trauma | 156 | 0.97 | (0.82, 1.16) | 0.77 | 0.99 | (0.83, 1.19) | 0.93 |
| Other | 322 | 1.11 | (0.99, 1.24) | 0.08 | 1.16 | (1.03, 1.31) | 0.02 |
CI=confidence interval; FFA=free fatty acids, HR=hazard ratio; SD=standard deviation SD of FFA = 0.2mEq/L. Total person-years = 54,167. Model 1: adjusted for age, sex, race, clinic and education (n = 4707). Model 2: adjusted for age, sex, race, clinic, education, BMI, cystatin C, albumin, physical activity, alcohol intake, smoking, hormone replacement therapy, self-reported health status, systolic blood pressure, LDL cholesterol, HDL cholesterol, hypertensive medication and lipid-lowering medication (n = 4620). Types of mortality were defined as: cardiovascular (coronary heart disease, stroke, or other atherosclerotic disease), cancer (any type), dementia, infection (pneumonia, sepsis or other infection), respiratory, trauma (includes fractures) or other (liver disease, gastrointestinal disease, renal failure, ALS, Parkinson’s disease, bladder disease, metabolic conditions, amyloid, failure to thrive, myelodysplastic syndrome, and other musculoskeletal diseases).